Pills or paintings? Swiss town lets doctors prescribe free museum visits as art therapy
ADVERTISEMENT
Stressed? Feeling run down? In need of a little pick-me-up? Well, if you're in the Swiss town of Neuchâtel, you might just get a doctor's note to visit a
museum
— for free.
In a novel pilot project launched by local and regional authorities, doctors can now prescribe "museum visits" as part of a treatment plan. This initiative, which covers the cost of entry to any of the town's four museums, aims to boost mental health and provide some cultural respite for patients.
The idea isn't just about enjoying
art
; it's backed by science. A 2019
World Health Organization
report highlighted the numerous mental health benefits of engaging with the arts. From reducing the impact of trauma to slowing cognitive decline, art therapy has been shown to have a positive impact on overall well-being.
'Art can help relax the mind, almost like preventative medicine,' said Julie Courcier Delafontaine, a Neuchâtel council member. 'People realised during the
Covid crisis
, when cultural sites were closed, just how much we need these spaces to feel better.'
The Musée d'art et d'histoire in Neuchâtel
Martouf / CC licence
Since launching, the programme has distributed around 500 prescriptions, with only a modest budget of 10,000 Swiss francs (roughly €10,460). If successful, local officials are considering expanding it to include other cultural activities like theatre or dance. Though the Swiss national health system currently doesn't cover '
culture as therapy
,' Courcier Delafontaine hopes it might in the future.
Marianne de Reynier Nevsky, the cultural mediation manager in Neuchâtel, was instrumental in creating the programme, drawing inspiration from a similar initiative launched in
Montreal
in 2019. She believes a wide range of patients could benefit, from those suffering depression to those with chronic illnesses or mobility issues.
'It could be a person with depression, a person who has trouble walking, a person with a chronic illness,' Nevsky explained. The key is encouraging patients to get out of the house, walk, and engage with their surroundings — even if it's just for an hour in a museum.
Dr. Marc-Olivier Sauvain, head of surgery at the Neuchâtel Hospital Network, has already prescribed museum visits to patients. For those preparing for surgery, it's an opportunity to get fit and active before going under the knife. He believes a more widespread rollout will help get more patients moving.
'I think these patients will fully benefit from museum prescriptions,' Sauvain said. 'It's a chance to get both physical and intellectual exercise.'
And it's not just the doctors who are excited. Carla Fragniere Filliger, a retired teacher and poet, was all for the idea during a recent visit to the Ethnographic Museum. 'I think it's a great idea,' she said. 'There should be prescriptions for all the museums in the world!'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euronews
8 hours ago
- Euronews
EU long-term budget: Is health funding on the chopping block?
Emerging priorities such as defence and competitiveness are increasingly drawing resources away from other sectors, raising concerns that health – a key focus of the previous EU mandate – may pay the highest price in the upcoming long-term EU budget. The European Commission is expected to unveil its proposal for the next seven-year budget in July. However, early leaks and mounting speculation suggest that the dedicated health fund could be merged with broader funding instruments, or potentially scrapped altogether. Although health policy is primarily the responsibility of national governments, EU member states allocated €5.3 billion for health through the EU4Health programme in response to the COVID-19 pandemic. This marked the first time a standalone health budget was created at the EU level. Prior to this, EU health initiatives operated with much smaller resources: The health programme for 2014–2020 had a total budget of just €450 million, significantly less than EU4Health. Since its launch, EU4Health has financed a range of initiatives, such as a recent €1.3 million project to address the nursing shortage across Europe by promoting the profession in countries most affected. Yet many fear that the programme will not survive the next programming cycle. Even some EU officials have hinted that EU4Health may have been a one-time measure. Lawmakers have raised alarms about the potential disappearance of EU4Health and its impact on flagship initiatives from the previous term, such as the Beating Cancer Plan. Croatian MEP Tomislav Sokol pointed out the importance of maintaining a dedicated health budget since health has become one of the most important topics in the EU after the pandemic. For this reason, the EU has opted to create a separate health programme within the bloc's budget to support initiatives like the EU health data space and the European reference networks. 'If we're not able to protect this, I'm afraid this will all be diluted and absorbed by some other big funds in the budget, and we will lose this focus on healthcare that we have now,' he told Euronews. Sokol also cited newer priorities like the Critical Medicines Act, arguing that they, too, will require substantial EU funding. "Of course, healthcare remains largely a national responsibility, but EU support is needed to create a level playing field across member states," he added. Concerns over future health investment stem in part from recent budget reallocations. In February 2024, approximately €1 billion was redirected from EU4Health to help finance an aid package for Ukraine. The looming cuts are causing anxiety in the health sector. The PHSSR – a coalition of academics, policymakers, and politicians working on sustainable health systems – highlighted the need for continued investment in a recent report ahead of the Commission's proposal. In an interview with Euronews, AstraZeneca senior vice-president Greg Rossi, who participated in the PHSSR, stressed that Europe risks falling behind in life sciences. "We're seeing massive innovation and opportunity in improving health outcomes. My area, cancer, has seen extraordinary advances in the last 10 to 15 years. But Europe is losing ground," he said, adding that research and development funding has declined, with clinical trials increasingly moving out of Europe. He warned that, without specific health investment initiatives like a dedicated EU health funding, access to innovation will worsen, health outcomes will deteriorate, and Europe's competitive edge will erode. 'Health is an investment to be made, not a cost to be managed. And if we do so, we'll improve the health and the wealth of our countries,' he said. The European Commission is preparing a comprehensive overhaul of the its long-term budget, also known as Multiannual Financial Framework (MFF) post-2027. The aim is to make it simpler, more effective, and more aligned with evolving policy priorities. Currently, the MFF stands at around €1.2 trillion – roughly 1% of the EU's GDP. Commission President Ursula von der Leyen is considering a major restructuring of the MFF for 2028–2034, possibly moving away from the current system of over 50 EU-level programmes. Budget Commissioner Piotr Serafin previously indicated that the next budget proposal will focus on "fewer, more focused programmes" and a more strategic, ambitious framework. The European Commission's proposal, expected in mid-July, will offer the first concrete signal of what lies ahead for health funding in the EU.
France 24
16 hours ago
- France 24
Germany's BioNTech to buy CureVac to boost cancer research
BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies". Both biotech companies have been working for years in the area of mRNA vaccines and treatments, which provoke an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells. While the technology became well known in relation to some Covid-19 vaccines, it is also being used in other areas, and scientists believe it could be a game-changer against many diseases. BioNTech said the acquisition of CureVac would help boost its work in the field of mRNA-based cancer immunotherapy -- treatment that uses the body's own immune system to fight diseases. "This transaction is another building block in BioNTech's oncology strategy and an investment in the future of cancer medicine," said BioNTech CEO Ugur Sahin. It was aimed at "establishing new standards of care for various types of cancer in the coming years," he said. Alexander Zehnder, CEO of CureVac, said the purchase would bring scientific expertise, technology and manufacturing know-how "in the mRNA field under one roof". BioNTech's all-stock acquisition has been unanimously approved by the companies' management and supervisory boards, and is expected to close in 2025, subject to certain conditions including regulatory approvals. Both companies are listed on the Nasdaq Composite Index. They had both sought to develop Covid-19 vaccines during the pandemic, with Mainz-based BioNTech's Comirnaty jab winning approval and going on to become one of the most widely used shots against the virus around the world. But Tuebingen-based CureVac, founded 25 years ago by mRNA pioneer Ingmar Hoerr, abandoned its efforts in late 2021 after disappointing trial results. In 2022, CureVac sued BioNTech for patent infringement over its rival's use of the technology.
LeMonde
2 days ago
- LeMonde
In bed and on the job: How to stay productive while lying down
With the democratization of remote work, our potential workspaces have expanded to include an unexpected area from which it is now accepted that one can move projects forward like Sisyphus in pajamas: the bed. Indeed, when working from home, it is tempting to abandon the uncomfortable sitting posture and, at some point, relocate to that soft and rectangular haven that seems to beckon us. Let anyone who has never attended a remote meeting from their mattress throw the first memory foam pillow at me! Although difficult to quantify, this trend seems to have taken root. A study conducted in 2020 by Tuck Sleep, which researches sleep for commercial purposes, showed that the Covid-19 pandemic had the side effect of increasing the amount of work done from bed. Among the 1,000 Americans surveyed, 8.8% spent between 24 to 40 hours per week in a paradoxical state of being both supine and productive. Even though it evokes a sense of hedonism, calling to mind the tutelary figures of Alexandre le Bienheureux (the indolent hero of the 1968 French cult film Very Happy Alexander) or Playboy founder Hugh Hefner – or even Winston Churchill, who also worked from his bed – this posture is sometimes a necessity, dictated by the lack of a proper desk in small apartments. Despite its promises of an improbable mix between work and leisure, it often proves uncomfortable in practice. As a passive variable in a society where information flows rapidly, you may find yourself at risk for back pain or a stiff neck caused by an excessively static posture. All the micro-efforts you make during a day at the office without even realizing it (walking to the printer, the cafeteria or grabbing a coffee) vanish if you spend the majority of your working life lying down. This extreme sedentarity, which takes you from bed to bed, is accompanied by increased morbidity, exacerbating cardiovascular, metabolic and musculoskeletal issues. Hybrid spaces Despite its risks, this temptation has become a new market, as evidenced by the fact that, on Amazon, one can purchase an intriguing cushion-desk on which to place a laptop and a latte, working while feeling like you're having breakfast at a hotel. Ikea has even launched a section on its website titled "How to work comfortably (and productively) from bed," where the hybridization of spaces dominates, neither truly restful places nor entirely credible work zones. Hence the recurring joke on TikTok, under the hashtag #WorkFromBed, in which an employee emerging from under the covers declares vindictively, "Oh, I'm at the office now!" In a Reddit conversation dedicated to the theme of working from bed, it is clear that the reasons motivating this practice are very eclectic: pain (such as menstrual cramps), fatigue, the comfort provided by blankets, depression, the demand to work from wherever one wishes, the creative necessity to let one's mind wander... Nevertheless, all of this requires certain arrangements to ensure that the realms of work and rest do not become completely indistinguishable. "I just make sure to have a transition between work and sleep: put away the laptop, go to other spaces to do something else before going to bed," shares BostonBluestocking. Is the horizontal worker not, ultimately, the most perfected product of a deverticalized working world, at last?
